1Centre for Human Drug Research, Leiden. ac@chdr.nl
Bevacizumab, a vascular endothelial growth factor inhibitor, prolongs disease-free survival in metastatic colorectal cancer. This targeted therapy shows promise by hindering tumor growth and metastasis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: